| Authors: |
Gutner CA; ViiV Healthcare, Durham, NC, USA., van der Valk M; Department of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam and Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Portilla J; Hospital General Universitario Dr Balmis de Alicante, Alicante, Spain., Jeanmaire E; Service de Maladies Infectieuses et Tropicales, Hôpital Brabois, CHRU de Nancy, Vandoeuvre-lès-Nancy, France., Belkhir L; Cliniques Universitaires Saint-Luc, Brussels, Belgium., Lutz T; Infektiologikum, Frankfurt am Main, Germany., DeMoor R; GSK, Collegeville, PA, USA., Trehan R; ViiV Healthcare, London, UK., Scherzer J; ViiV Healthcare, Munich, Germany., Pascual-Bernáldez M; ViiV Healthcare, Madrid, Spain., Ait-Khaled M; ViiV Healthcare, London, UK., Hernandez B; ViiV Healthcare, Madrid, Spain., de Ruiter A; ViiV Healthcare, London, UK., Anand SB; Evidera, London, UK., Low EL; Evidera, London, UK., Hadi M; Evidera, London, UK., Barnes N; Evidera, London, UK., Sevdalis N; Centre for Behavioural and Implementation Science Interventions, Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge, Singapore., Mohammed P; ViiV Healthcare, London, UK., Czarnogorski M; ViiV Healthcare, Durham, NC, USA. |
